Free Access
Med Sci (Paris)
Volume 32, Number 4, Avril 2016
Page(s) 417 - 422
Section Forum
Published online 02 May 2016
  1. Jordan B. Biopsies liquides, une révolution en cancérologie ? Med Sci (Paris) 2015 ; 31 : 805–807. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Jordan B. Dépistage du cancer : les promesses illusoires de Pathway Genomics. Med Sci (Paris) 2015 ; 31 : 1137–1139. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Snyder MW, Kircher M, Hill AJ, et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 2016 ; 164 : 57–68. [CrossRef] [PubMed] [Google Scholar]
  4. Ignatiadis M, Lee M, Jeffrey SS. Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility. Clin Cancer Res 2015 ; 21 : 4786–4800. [CrossRef] [PubMed] [Google Scholar]
  5. Prasad V, Lenzer J, Newman DH. Why cancer screening has never been shown to save lives and what we can do about it. Br Med J 2016 ; 352 : h6080. [CrossRef] [PubMed] [Google Scholar]
  6. Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014 ; 15 : e234–e242. [CrossRef] [PubMed] [Google Scholar]
  7. Hugosson J, Carlsson S. Overdetection in screening for prostate cancer. Curr Opin Urol 2014 ; 24 : 256–263. [CrossRef] [PubMed] [Google Scholar]
  8. Aaronson DS, Redberg RF. Use of prostate-specific antigen testing is in the eye of the beholder. JAMA Intern Med 2016 ; doi: 10.1001/jamainternmed.2015.8104. [Google Scholar]
  9. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012 ; 367 : 1998–2005. [CrossRef] [PubMed] [Google Scholar]
  10. Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. Br Med J 2013 ; 346 : f385. [CrossRef] [PubMed] [Google Scholar]
  11. Schreier G. The internet of things for personalized health. Stud Health Technol Inform 2014 ; 200 : 22–31. [PubMed] [Google Scholar]
  12. Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 2011 ; 8 : 184–187. [CrossRef] [PubMed] [Google Scholar]
  13. Billaud M, Guchet X. L’invention de la médecine personnalisée. Med Sci (Paris) 2015 ; 31 : 797–803. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.